Senior Director, Care Pathway Optimization & Health System Strategy

Ipsen; Cambridge (MA); Hybrid; USD 218,000 - 315,000; Full time

Benefits offered by this job

401(k) with company contributions

Health insurance

Dental and Vision

Life and Disability Insurance

Well-being allowance

Parental leave

Paid time off

Job summary

Ipsen Biopharmaceuticals Inc. seeks a Senior Director, Head of Care Pathway Optimization to establish and lead a new strategic capability accelerating diagnosis and optimizing care pathways across the U.S.

rare disease portfolio. The role defines vision, operating model, and success metrics while partnering with healthcare systems to improve the patient journey from identification through treatment initiation.

Qualifications

• Minimum 15+ years in Pharma/Biotech/Med Devices.
• Proven leadership of teams driving care pathway optimization.
• Deep understanding of health system operations and provider economics.
• Experience with health data sources (claims, EHR, etc.).
• Ability to develop partnerships with IDNs/provider groups.

Responsibilities

• Establish enterprise strategy for diagnosis acceleration and care pathway optimization across the U.S. portfolio.
• Define vision, operating model, priorities and success measures for Care Pathway Optimization.
• Build and lead a scalable organization with top talent.
• Identify and address barriers in patient journey from diagnosis to treatment.
• Partner with data teams to leverage analytics and insights to guide decisions.
• Lead external partnerships with institutions to improve patient care pathways.
• Drive programs that accelerate diagnosis and optimize care pathways for rare diseases.

Skills

Health systems

Team leadership

Healthcare data

Strategic partnerships

Cross-functional

Patient journey

Provider economics

Education

Bachelor’s Degree

MBA

MPH

MS

PhD

Job description

Ipsen Biopharmaceuticals Inc. seeks a Senior Director, Head of Care Pathway Optimization to establish and lead a new strategic capability accelerating diagnosis and optimizing care pathways across the U.S.

rare disease portfolio. The role defines vision, operating model, and success metrics while partnering with healthcare systems to improve the patient journey from identification through treatment initiation.